Hemopoiesis

Title

Date Published

Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacists.

October 13, 2009

An update on iron physiology.

October 7, 2009

Intravenous iron in inflammatory bowel disease.

October 7, 2009

Use of agents stimulating erythropoiesis in digestive diseases

October 7, 2009

A case of iron deficiency anemia in which iron absorption increased after Helicobacter pylori eradication

October 1, 2009

Iron sequestration and anemia of inflammation

October 1, 2009

Anemia is a predictor of outcome in heart transplant recipients

October 1, 2009

Anemia management with darbepoetin-alfa in outpatient hemodialysis patients switched from epoetin-alfa: A community hospital experience

September 29, 2009

Ascorbic acid for anemia management in hemo-dialysis patients: a systematic review and meta-analysis

September 22, 2009

Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery

September 3, 2009

Update on the use of erythropoiesis- stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma

September 2, 2009

Erythropoietin in patients with acute coronary syndrome and its cardioprotective action after percutaneous coronary intervention

August 19, 2009

Anemia is an independent predictor of long-term adverse outcomes in patients hospitalized with heart failure in Japan. A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD).

August 4, 2009

Anemia is an independent predictor of long- term adverse outcomes in patients hospitalized with heart failure in Japan

August 4, 2009

The clinical impact of the physiological effects of erythropoietin and erythropoietin- stimulating agents on the incidence of malignancy, and hypertension: Beyond anaemia

August 1, 2009

A field guide to iron needs in the patient on hemodialysis

July 31, 2009

Erythropoiesis-stimulating agents in patients with cancer: update on safety issues

July 29, 2009

Erythropoietin or Darbepoetin for patients with cancer–meta-analysis based on individual patient data

July 8, 2009

Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report.

July 6, 2009

Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study

July 1, 2009